Sun Pharma
Sun Pharma's shares are in the spotlight as the company announced on Saturday that a U.S. court has issued a preliminary injunction preventing the launch of ...
Jefferies has added 10 new stocks to its Buy list for September, bringing the total to 28 stocks. Some of the key additions include Coal India, ITC Ltd, ...
For the upcoming September series, Rajesh Palviya of Axis Securities has shared his insights on the market outlook and top stock picks.Market Outlook for ...
Pharma stocks have caught the attention of investors again, with the Nifty Pharma index reaching new highs on Tuesday. Investors are turning to the pharma ...
Rajesh Palviya from Axis Securities has shared three stock recommendations for the coming week. He believes there is still potential for further gains in ...
The Nifty Pharma Index has jumped 34% so far this year, beating the Nifty-50 benchmark, which is up just over 14%. In the last month alone, the Pharma Index ...
Prabhudas Lilladher is positive on Sun Pharmaceutical Industries and has given a buy rating with a target price of Rs 1885 in their research report dated ...
The Budget week didn't bring much excitement to the market as the government's measures were both populist and prudent. The increase in short- and long-term ...
On Friday, Sun Pharma announced that the US Food and Drug Administration (FDA) approved their new drug, Leqselvi (deuruxolitinib) 8 mg tablets, for treating ...
India's involvement has significantly boosted Bangladesh's pharmaceutical industry, said the Indian envoy at the inauguration of a new plant by a top Indian ...